Theranostics · 2022 · 41 citations · 28 references
MedicineCardiologyCell BiologyEpigeneticsRegenerative MedicineStem Cell BiologyAngiogenesisCardiac RegenerationCell-based TherapiesEndothelial ActivationEndothelial DysfunctionAutologous Stem Cell TherapyBone Marrow - Derived CellsCardioprotective TherapyDiabetes-associated Vascular ChangesEndothelial Progenitor CellsExtracellular VesiclesPost-translational Histone ModificationsProgenitor Cells
Our findings unravel that diabetes impairs EPC-EV reparative function in the ischemic heart, at least partially, through HDACs-mediated H3K9Ac downregulation leading to transcriptional suppression of angiogenic, proliferative and cell survival genes in recipient cardiac ECs. Thus, HDAC inhibitors may potentially be used to restore the function of diabetic EPC and other stem cells for autologous cell therapy applications.
28
Min Xiu, Juanjuan Xing, Shaoqing Yu et al. · Cellular Physiology and Biochemistry · 2017 · 5.8K citations · Full text
Daniella Brasacchio, Jun Okabe, Christos Tikellis et al. · Diabetes · 2009 · 531 citations · Full text
Louisa M. Villeneuve, Marpadga A. Reddy, Linda Lanting et al. · Proceedings of the National Academy of Sciences · 2008 · 411 citations · Full text
Life Sciences, Genetics, Diabetology +13